HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 13365983, compound → 1,1-Dioxido-2-(4-(4-(2-oxo-(1H)-quinolin-1-yl)-piperidin-1-yl)-butyl)-5-nitro-1,2-benzisothiazol-3(2H)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 13365983 | HCID 13365983 | — |
| Reactant | HCID 19085848 | HCID 19085848 | — |
| Product | 1,1-Dioxido-2-(4-(4-(2-oxo-(1H)-quinolin-1-yl)-piperidin-1-yl)-butyl)-5-nitro-1,2-benzisothiazol-3(2H)-one | HCID 19085850 | — |
Reaction Steps
From the hydrochloride salt of 1-(4-piperidyl)-2(1H)-quinolinone prepared according to H. Ogawa et. al. J. Med. Chem. 1993, 36, 2011-2017, and 2-(4-bromobutyl)-5-nitro-1,1-dioxido-1,2-benzothiazol-3(2H)-one using the procedure described for Example 15, Step 5 there was obtained a white solid: 1H NMR (300 MHz, CDCl3) 8.88 (d, J=1.9 Hz, 1H), 8.73 (dd, J=8.36, 1.71 Hz, 1H), 8.15 (d, J=8.36 Hz, 1H), 7.79 (br m, 1H), 7.62 (d, J=3.47 Hz, 1H), 7.51 (m, 2H), 7.20 (m, 2H), 6.66 (d, J=9.33 Hz, 1H), 3.91 (t, J=7.33 Hz, 2H), 2.85 (br m, 2H), 2.48 (t, J=8.27 Hz, 2H), 2.21 (t, J=10.65 Hz, 2H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05760054 |
| Source dataset | uspto-grants-1998_06 |
| ORD ID | ord-f6eb3b3baf1049d0b7045af9ff505c33 |
| Source note | uspto-grants-1998_06 |